NutraLife BioSciences, Inc.
NLBS
OTC PK
| 09/30/2022 | 06/30/2022 | ||||
|---|---|---|---|---|---|
| Revenue | 106.27% | -30.68% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 106.27% | -30.68% | |||
| Cost of Revenue | 338.30% | -96.18% | |||
| Gross Profit | 84.77% | 220.19% | |||
| SG&A Expenses | -33.92% | 6.28% | |||
| Depreciation & Amortization | 0.00% | -26.40% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -28.48% | -12.71% | |||
| Operating Income | 40.03% | 10.74% | |||
| Income Before Tax | -30.83% | 16.95% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -30.83% | 16.95% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -30.83% | 16.95% | |||
| EBIT | 40.03% | 10.74% | |||
| EBITDA | 44.26% | 8.68% | |||
| EPS Basic | -31.37% | 17.74% | |||
| Normalized Basic EPS | -31.25% | 17.95% | |||
| EPS Diluted | -31.37% | 17.74% | |||
| Normalized Diluted EPS | -31.25% | 17.95% | |||
| Average Basic Shares Outstanding | 0.34% | 0.94% | |||
| Average Diluted Shares Outstanding | 0.34% | 0.94% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
